SCHEMBL328477

SCHEMBL328477

CCCC(CCC)C(=O)N(C)CCN(CC(N)=O)S(=O)(=O)c1cc(F)c(Oc2ccc(Cl)cc2)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.35
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
DAGLA Q9Y4D2 2/20 0.34
CA2 P00918 1/20 0.33
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
ALDH1A1 P00352 3/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
UTS2R Q9UKP6 2/20 0.31
KMT2A Q03164 2/20 0.31
SLC9A3 P48764 1/20 0.31
PPARD Q03181 1/20 0.31
PPARA Q07869 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6863166 0.90 MMP1 (0.40) CA9CA2LMNABMP1
SCHEMBL328478 0.84 LMNA (0.35) CA1CA12CA9DAGLALMNA
SCHEMBL328658 0.83 HSP90AA1 (0.41) CA1CA12CA9DAGLALMNA
SCHEMBL328414 0.83 DAGLA (0.37) CA1CA12CA9DAGLATHRB
SCHEMBL6850664 0.82 DAGLA (0.43) DAGLAALDH1A1L3MBTL1SLC9A3
SCHEMBL328661 0.82 KMT2A (0.38) CA1CA12CA9DAGLATHRB
SCHEMBL328548 0.82 DAGLA (0.37) CA1CA12CA9DAGLATHRB
SCHEMBL328662 0.81 MEN1 (0.39) DAGLAL3MBTL1UTS2RKMT2A
SCHEMBL328412 0.81 MMP3 (0.37) KMT2A
SCHEMBL10066710 0.80 LSS (0.41) CA1CA12CA9DAGLAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428509-A1 Human adam-10 inhibitors Symphony Evolution, Inc. (US) 2012-03-14 EP disclosed
WO-2011011181-A1 PHARMACOLOGICAL CHAPERONES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AMICUS THERAPEUTICS, INC. (US) 2011-01-27 WO disclosed